Study held to see the effect of intake of Asthimajjapachak churna as compared with Shwadamshtradi Rasayan churna in the treatment of hairfall in females.

"A clinical comparative study of efficacy of Asthimajjapachak churna and Shwadamshtradi Rasayan churna in Keshapatan in females."

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029227

Enrollment

Registered

2020-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Asthimajjapachak churna: Oral intake of Asthimajjapachak churna prepared from powders of Emblica officinalis,Tinospora cordifolia,Cyperus rotundus ,1.5gm at morning and 1.5gm at evening

Eligibility

Inclusion criteria

Inclusion criteria: Female patients between age group from 16 to 50 years with any socio-economic status having hairfall with dryness of hair and split ends.

Exclusion criteria

Exclusion criteria: Patients with any major systemic illness eg. Cancer,T.B.etc Patients having Alopacia areata,Alopacia totalis,Tinea capitis,Folliculitis decalvance and arunshika,indralupta. surgical indications. pregnancy and lactating mothers.

Design outcomes

Primary

Measure	Time frame
Asthimajjapachak churna and Shwadamshtradi Rasayan churna are eqally effective in management of Keshapatan(hairfall)Timepoint: 30 days study with follow ups on 7th, 15th, 21st and 30th day.	—

Secondary

Measure	Time frame
Asthimajjapachak churna is more effective than Shwadamshtradi Rasayan churna in management of Keshapatan (hairfall)Timepoint: 30 days study with follow ups on 7th, 15th, 21st and 30th day.	—

Countries

India

Contacts

Public ContactTejaswini Radhakrishna Prabhudesai

Dr. D. Y. Patil college of Ayurveda and research centre

mrudula.doctor@gmail.com9226279270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026